Verified Nov 2026
Other
·

Rockland, Massachusetts
·
Since
EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.
EMD Serono, Inc. at a glance
Revenue
$500M-1B
Est. band
Employees
1,000-5,000
Headquarters
Rockland, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.
At a glance
Attribute | Detail |
|---|---|
Headquarters | Rockland, Massachusetts |
Employees | 1,000-5,000 |
Revenue | $500M-1B (estimated) |
What EMD Serono, Inc. makes
The company provides drug-delivery devices alongside eight marketed drugs in the U.S. since 2017 and offers comprehensive patient support services throughout treatment.
Products and capabilities described on the company's own site include Electronics, Steel, Lighting (source: emdserono.com).
Latest developments
2026-11-11 — Pimicotinib FDA approval (emdgroup.com)
2026-09-09 — PostEra's Fertility programs acquired by EMD Serono, Inc. (prnewswire.com)
2026-06-24 — EMD Serono Announces Healthcare Leadership Changes for Global Commercial Strategy and North America - News | EMD Serono (emdserono.com)
2026-06-23 — EMD Serono Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies - News | EMD Serono (emdserono.com)
2026-02-06 — EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities - News | EMD Serono (emdserono.com)
2025-11-24 — EMD Serono Brings Innovation to the Treatment of Generalized Myasthenia Gravis - NEWS | EMD Serono (emdserono.com)
Facilities
EMD Serono, Inc. is headquartered in Rockland, Massachusetts. Public sources also reference these locations:
Italy — packagingdigest.com
Company details
EMD Serono operates as a subsidiary of Merck KGaA with research and manufacturing sites across multiple U.S. locations and maintains active collaborations with external research partners such as Versant Ventures. EMD Serono, Inc. has an estimated 1,000-5,000 employees, and is headquartered in Rockland, Massachusetts.
Frequently asked questions
What does EMD Serono, Inc. do?
EMD Serono is the U.S. and Canadian biopharmaceutical division of Merck KGaA, headquartered in Rockland, Massachusetts, with 1,000–5,000 employees and revenue between $500M–1B. The company develops therapies in neurology, endocrinology, oncology, and immunology, serving patients with multiple sclerosis, infertility, cancer, and myasthenia gravis. In 2026, the company received FDA approval for pimicotinib and acquired PostEra's fertility programs to expand its treatment portfolio.
Where is EMD Serono, Inc. headquartered?
EMD Serono, Inc. is headquartered in Rockland, Massachusetts (1 Technology Place, Rockland, Massachusetts, 02370).
How big is EMD Serono, Inc.?
EMD Serono, Inc. has an estimated 1,000-5,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
